Company: BIVIW
Filing Date: 2025-07-11
Form Type: S-1/A
Source: 0001520138-25-000205
Chunk: 178

Company: BIOVIE INC.
Filing Date: 2025-07-11
Form: S-1/A
Chunk 178
---
 |
| Cash                                                    |     | $                          | 12,763,941 |     | $       | - |     | $       | - |     | $     | 12,763,941 |
| U.S. Treasury Bills due in 3 months or less at purchase |     |                            | 11,079,857 |     |         | - |     |         | - |     |       | 11,079,857 |
| Total                                                   |     | $                          | 23,843,798 |     | $       | - |     | $       | - |     | $     | 23,843,798 |

|                                                         |     | Fair Value Measurements at 
 June 30, 2023              |            |     |         |   |     |         |   |     |       |            |
|:--------------------------------------------------------|:----|:---------------------------|-----------:|:----|:--------|:--|:----|:--------|:--|:----|:------|-----------:|
|                                                         |     | Level 1                    |            |     | Level 2 |   |     | Level 3 |   |     | Total |            |
| Cash                                                    |     | $                          |  6,304,543 |     | $       | - |     | $       | - |     | $     |  6,304,543 |
| U.S. Treasury Bills due in 3 months or less at purchase |     |                            | 13,156,340 |     |         | - |     |         | - |     |       | 13,156,340 |
| U.S. Treasury Bills due in 3 - 6 months at purchase     |     |                            | 14,477,726 |     |         | - |     |         | - |     |       | 14,477,726 |
| Total                                                   |     | $                          | 33,938,609 |     | $       | - |     | $       | - |     | $     | 33,938,609 |

| 9. | Equity Transactions |

Issuance of common stock for cash

On August 31, 2022, the Company entered into a Controlled
Equity Offering Sales Agreement (the “Sales Agreement”) with Cantor Fitzgerald & Co. and B. Riley Securities, Inc. (collectively,
the “Agents”), pursuant to which the Company may issue